Tympanostomy tube otorrhea (TTO) is a frequent complication associated with tympanostomy tube (TT) insertion in young children. Despite the standard treatment using topical antibiotics, TTO is often persistent or recurrent due to biofilm development on TT. In this study, we developed a novel antimicrobial blue light (aBL; 405nm) activatable Optical-TT, which emits aBL from the entire TT surface to kill major otopathogens in biofilms on TT. Our preliminary results showed that the Optical-TT activated by aBL led to over 2.5-log10 CFU reduction in 120 h-old H. influenzae films and 48 h-old P. aeruginosa biofilms formed on TT after 30 J/cm2 aBL and in 48 h-old S. aureus biofilms formed on TT after 60 J/cm2, implying the potential of aBL-activable Optical-TT in the management of TTO. Animal studies using a chinchilla model of TTO are currently underway.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.